Managers / Q1 2022 · view latest →
VK Services, LLC
CIK 0001501927 · 2128 SAND HILL ROAD, MENLO PARK, CA, 94025 · (650) 376-8526
Summary
Vk Services, LLC reported $2.0B in U.S.-listed holdings across 10 positions for Q1 2022.
The portfolio is heavily concentrated: Rocket Lab USA alone accounts for 42.7% of reported value.
Compared with Q4 2021, the fund opened 1 new position and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Other · 73.5% · $1.4B
- Common Stock · 26.5% · $517M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| GREENLIGHT BIOSCIENCES HOLDINGS PBC | NEW | +5.22M | 5.22M | +$50M | $50M |
| QSQUANTUMSCAPE CORPORATION | TRIMMED | −3.54M | 1.29M | −$114M | $26M |
| DASHDOORDASH INC. | TRIMMED | −901.0K | 1.24M | −$264M | $153M |
| OPENOPENDOOR TECHNOLOGIES INC | TRIMMED | −4.45M | 8.90M | −$239M | $77M |
| AFRMAFFIRM HLDGS INC | TRIMMED | −1.26M | 3.12M | −$567M | $144M |
| ROCKET LAB USA INC | TRIMMED | −11.50M | 103.50M | −$1.0B | $833M |
| BERKSHIRE GREY INC | HELD | +0 | 56.57M | −$227M | $163M |
| VICARIOUS SURGICAL INC | HELD | +0 | 20.96M | −$168M | $106M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2022
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | ROCKET LAB USA INC | COMMON STOCK | 42.69% | $833M | 103.50M |
| 2 | VELO3D INC | COMMON STOCK | 14.48% | $283M | 30.35M |
| 3 | BERKSHIRE GREY INC | CLASS A COMMON STOCK | 8.35% | $163M | 56.57M |
| 4 | DASHDOORDASH INC.history → | CLASS A COMMON STOCK | 7.85% | $153M | 1.24M |
| 5 | AFRMAFFIRM HLDGS INChistory → | CLASS A COMMON STOCK | 7.39% | $144M | 3.12M |
| 6 | OSCROSCAR HEALTH INChistory → | CLASS A COMMON STOCK | 5.98% | $117M | 11.70M |
| 7 | VICARIOUS SURGICAL INC | CLASS A COMMON STOCK | 5.43% | $106M | 20.96M |
| 8 | OPENOPENDOOR TECHNOLOGIES INChistory → | COMMON STOCK | 3.94% | $77M | 8.90M |
| 9 | GREENLIGHT BIOSCIENCES HOLDINGS PBC | COMMON STOCK | 2.58% | $50M | 5.22M |
| 10 | QSQUANTUMSCAPE CORPORATIONhistory → | CLASS A COMMON STOCK | 1.32% | $26M | 1.29M |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $542,836 | 1 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | Under review | 2 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $404M | 3 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $770M | 2 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $388M | 2 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $849M | 2 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $455M | 5 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $410M | 7 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $549M | 7 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $660M | 7 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $750M | 10 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $880M | 11 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $676M | 11 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $568M | 9 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $671M | 7 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $671M | 11 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $2.0B | 10 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $4.6B | 9 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $4.4B | 11 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $3.0B | 7 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $4.3B | 7 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $2.8B | 5 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $0 | 1 | May 5, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $209M | 1 | Jan 31, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $296M | 1 | Oct 25, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $617M | 1 | Jul 18, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $548M | 1 | Apr 23, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $268M | 1 | Feb 13, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 5 additional managers.
- Khosla Ventures Associates III, LLC028-20988
- Khosla Ventures Associates IV, LLC028-19200
- Khosla Ventures Associates V, LLC028-20985
- Khosla Ventures Seed Associates B, LLC028-20986
- Khosla Ventures Seed Associates C, LLC028-21418
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.